CALR and colonic neoplasm: Blockade of CRT by Small interfering RNA (siRNA) or antibody in colon cancer cells compromised the immunogenicity of mitoxantrone-treated CT26 mouse, while the administration of recombinant CRT restored it to the cell surface.